Skip to results
Modify your search
NARROW
1-8 of 8
Authors: Kevin W Garey
Journal Article
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA Open Access
JAC-Antimicrobial Resistance, Volume 5, Issue 1, February 2023, dlac131, https://doi.org/10.1093/jacamr/dlac131
Published: 02 January 2023
Journal Article
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects Open Access
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3635–3643, https://doi.org/10.1093/jac/dkaa364
Published: 06 September 2020
Journal Article
In vitro activity of eravacycline against common ribotypes of Clostridioides difficile Open Access
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 10, October 2020, Pages 2879–2884, https://doi.org/10.1093/jac/dkaa289
Published: 28 July 2020
Journal Article
Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 4, April 2020, Pages 859–867, https://doi.org/10.1093/jac/dkz513
Published: 24 December 2019
Journal Article
Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection Open Access
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 5, May 2016, Pages 1245–1251, https://doi.org/10.1093/jac/dkv498
Published: 18 February 2016
Journal Article
Treatment of Candida famata bloodstream infections: case series and review of the literature Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 2, February 2013, Pages 438–443, https://doi.org/10.1093/jac/dks388
Published: 19 October 2012
Journal Article
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 12, December 2011, Pages 2850–2855, https://doi.org/10.1093/jac/dkr377
Published: 21 September 2011
Journal Article
Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections Get access
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 3, September 2006, Pages 645–650, https://doi.org/10.1093/jac/dkl279
Published: 27 June 2006
